National health insurance to cover new rheumatism drug

Published: 2013-03-18 06:59:00
Updated: 2013-03-18 06:59:00
The Ministry of Health and Welfare said Thursday that Janssen Korea’s rheumatism medication Simponi (golimumab) will be covered by national health insurance through the public hearing.

Simponi, the first once-monthly subcutaneous anti-TNF-alpha therapy, was approved by the Food and Drug Admini...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.